Patents by Inventor Elaine Yee-Lin Kuo

Elaine Yee-Lin Kuo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions and methods for treating mast-cell mediated conditions
    Patent number: 6211228
    Abstract: Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.
    Type: Grant
    Filed: March 29, 1999
    Date of Patent: April 3, 2001
    Assignee: Axys Pharmaceuticals, Inc
    Inventors: Ken Duane Rice, Jeffrey Mark Dener, Anthony Robert Gangloff, Elaine Yee-Lin Kuo
  • Reversible cysteine protease inhibitors
    Patent number: 6030946
    Abstract: Cysteine protease inhibitors are provided.
    Type: Grant
    Filed: June 3, 1996
    Date of Patent: February 29, 2000
    Assignee: Axys Pharmaceuticals, Inc.
    Inventors: Jeffrey L. Klaus, David Rasnick, James T. Palmer, Elaine Yee-Lin Kuo
  • Compositions and methods for treating mast-cell mediated conditions
    Patent number: 6022969
    Abstract: Novel compounds, compositions and methods effective for the prevention and treatment of mast-cell mediated inflammatory disorders are described. The compounds, compositions and methods are effective for the prevention and treatment of inflammatory diseases associated with the respiratory tract, such as asthma and allergic rhinitis, as well as other types of immunomediated inflammatory disorders, such as rheumatoid arthritis, conjunctivitis and inflammatory bowel disease, various dermatological conditions, as well as certain viral conditions. The compounds comprise potent and selective inhibitors of the mast cell protease tryptase. The compositions for treating these conditions include oral, inhalant, topical and parenteral preparations as well as devices comprising such preparations.
    Type: Grant
    Filed: September 14, 1995
    Date of Patent: February 8, 2000
    Assignee: AXYS Pharmaceuticals, Inc.
    Inventors: Ken Duane Rice, Jeffrey Mark Dener, Anthony Robert Gangloff, Elaine Yee-Lin Kuo